期刊文献+

甲状腺乳头状癌中RUNX3基因启动子甲基化及其蛋白表达的研究 被引量:3

Methylation and expression of RUNX3 gene promoter in papillary thyroid carcinoma
原文传递
导出
摘要 目的探讨甲状腺乳头状癌(papillary thyroid carcinoma,PTC)组织中runt相关转录因子3(runt—related transcription factor3,RUNX3)基因启动子甲基化及其与蛋白的表达。方法采用甲基化特异性聚合酶链反应及免疫组化方法检测56例PTC及其对应的癌旁组织中RUNX3基因启动子甲基化及其蛋白的表达。结果在癌旁组织中,无一例出现RUNX3基因启动子甲基化,而在PTC组织中20例出现甲基化,且甲基化状态与PTC的TNM分期、病理分级及淋巴转移有关(P值均〈0.05);癌旁组织和PTC中,RUNX3蛋白表达的阳性率分别为100.0%和60.7%,P〈0.05。在PTC组中,在病理分级I级和Ⅱ级组中,RUNX3蛋白阳性率分别为70.0%和37.5%,淋巴转移阳性和阴性组分别为46.7%和76.9%,差异均有统计学意义(P值均〈0.05);RUNX3基因启动子甲基化与其蛋白表达有明显的相关性(x2=21.62,P〈0.01)。结论RUNX3基因启动子甲基化是该基因失活的重要机制之一;RUNX3蛋白表达下调可能对甲状腺乳头状癌的发生、发展具有重要作用。 Objective To study the relationship between status of methylation of human runt-related transcription factor 3 (RUNX3) gene promoter in papillary thyroid carcinoma (PTC). Methods Methylation-specific PCR and immunohistochemical SP technique were used to detect the methylation of RUNX3 gene promoter and expression of its protein in 56 cases of PTC and their matched adjacent non- carceious epithelium(NCE). Results In NCE, there was no methylation of RUNX3 gene promoter, while in PTC the methylation rate was 35.7% (20/56) , which was related to the tumor TNM stage, pathological grade and lymph node metastasis (P 〈 0. 05). The positive rates of RUNX3 protein expression in NCE and PTC were 100. 0% and 60. 7% , respectively, with a significant difference ( X2 = 27. 378, P 〈 0. 05 ). In PTC, the positive rates of RUNX3 protein expression in grade I and grade II were 70. 0% and 37.5% , respectively( P 〈 0. 05 ) ; the rates were 46. 7% and 76. 9% in lymph node metastasis group and no metastasis group, respectively (P 〈 0.05 ). Moreover, there was a distinct correlation between methylation of RUNX3 gene promoter and expression of its protein ( X2 = 21.62, P 〈 0. 01 ). Conclusions Methylation of promoter might be one of the important factors of inactivation of RUNX3 gene, and might play an important role in carcinogenesis and progression of PTC.
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2011年第5期417-419,共3页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
基金 基金项目:河南省医学科技攻关项目(201003036) 郑州大学第一附属医院青年创新基金项目(2009WQN001)
关键词 甲基化 免疫组织化学 核心结合因子仪3亚型 甲状腺肿瘤 乳头状 Methylation Immunohistochemistry Core binding factor alpha 3 subunit Thyroid neoplasm Carcinoma, papillary
  • 相关文献

参考文献2

二级参考文献22

  • 1殷德涛,董明敏.喉鳞状细胞癌中脆性组氨酸三联体基因微卫星的不稳定性和杂合性丢失[J].中华耳鼻咽喉头颈外科杂志,2005,40(1):45-48. 被引量:14
  • 2Li J,Yen C,Liaw D,et al.PTEN,a putative protein tyrosine phosphatase gene mutated in human brain,breast and prostate cancer.Science,1997,275:1943-1947.
  • 3Dahia PL,Marsh DJ,Zheng Z,et al.Somatic deletions and mutations in the Cowden disease gene,PTEN,in sporadic thyroid tumors.Cancer Res,1997,57:4710-4713.
  • 4Gimm O,Perren A,Weng LP,et al.Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue,and benign and malignant epithelial thyroid tumors.Am J Pathol.2000,156:1693-1700.
  • 5Halachmi N,Halachmi S,Evron E,et al.Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors.Genes Chromosomes Cancer,1998,23:239-243.
  • 6Yeh JJ,Marsh DJ,Zedenius J,et al.Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygoisty and surrests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways.Genes Chromosomes Cancer,1999,26:322-328.
  • 7Soria JC,Lee HY,Lee JI,et al.Lack of PTEN expression in nonsmall cell lung cancer could be related to promoter methylation.Clin Cancer Res,2002,8:1178-1184.
  • 8Alvarez-Nunez F,Bnssaglia E,Mauricio D,et al.PtEN promoter methylation in sporadic thyroid carcinomas.Thyroid,2006,16:17-23.
  • 9Salvesen HB,MacDonald N,Ryan A,et al.PTEN methylation is associated with advanced stage and microsatellite instability in endnometrial carcinoma.Int J Cancer,2001,91:22-26.
  • 10tallini G.Molecular pathobiology of thyroid neoplasms.Endocr Pathol,2002,13:271-288.

共引文献26

同被引文献24

  • 1Moses W,Weng J,Kebebew E.Prevalence,clinicopathologic features,and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer[J].Thyroid,2011,21(4):367-371.
  • 2Nemec J,Soumar J,Zamrazil V,et al.Familial occurrence of differentiated (non-medullary) thyroid cancer[J].Oncology,1975,32(3-4):151-157.
  • 3Park Y J,Ahn HY,Choi HS,et al.The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases[J].Thyroid,2012,22 (4):356-362.
  • 4Uchino S,Noguchi S,Kawamoto H,et al.Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population[J].World J Surg,2002,26(8):897-902.
  • 5Sadowski SM,He M,Gesuwan K,et al.Prospective screening in familial nonmedullary thyroid cancer[J].Surgery,2013,154 (6):1194-1198.
  • 6Mazeh H,Benavidez J,Poehls JL,et al.In patients with thyroid cancer of follicular cell origin,a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease[J].Thyroid,2012,22(1):3-8.
  • 7Suh I,Filetti S,Vriens MR,et al.Distinct loci on chromosome 1 q21 and 6q22 predispose to familial nonmedullary thyroid cancer:a SNP array-based linkage analysis of 38 families[J].Surgery,2009,146(6):1073-1080.
  • 8Xiong Y,Zhang L,Holloway A K,et al.MiR-886-3p regulates cell proliferation and migration,and is dysregulated in familial non-medullary thyroid cancer[J].PLoS One,2011,6 (10):e24717.
  • 9He M,Bian B,Gesuwan K,et al.Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer[J].Thyroid,2013,23 (3):301-307.
  • 10高楠,陈卫昌,岑建农.胃癌组织runt相关转录因子3基因表达与其甲基化状态的关系[J].中华肿瘤杂志,2008,30(5):361-364. 被引量:15

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部